WithdrawnPhase 3NCT04006691
Efficacy and Safety of UGN-101 in Recurrent Patients
Studying Medullary thyroid carcinoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- UroGen Pharma Ltd.
- Principal Investigator
- Ifat Klein, PhdUroGen Pharma
- Intervention
- UGN-101 instillations(drug)
- Eligibility
- 18 years · All sexes
- Timeline
- 2019 – 2020
Study locations (5)
- UCLA - University of California, Los Angeles, Los Angeles, California, United States
- Mayo Clinic Florida, Jacksonville, Florida, United States
- John Hopkins University, Baltimore, Maryland, United States
- Urology Center Las Vegas, Las Vegas, Nevada, United States
- Sheba Medical Center, Ramat Gan, Israel
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04006691 on ClinicalTrials.govOther trials for Medullary thyroid carcinoma
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT07566156Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer ( EV-309 )Astellas Pharma Global Development, Inc.
- RECRUITINGPHASE3NCT07383246CTR-FAPI-guided Precision Surgery for Newly Diagnosed MTCCancer Institute and Hospital, Chinese Academy of Medical Sciences
- RECRUITINGNCT07142005Cultural Adaptation of an Educational Tool in Medullary Thyroid CancerM.D. Anderson Cancer Center
- RECRUITINGNANCT07138716Research on the Application of 68Ga-DOTA-CCK-FS PET/CT in MTCLuo Yaping
- ENROLLING BY INVITATIONNCT06852144PET-TC in Thyroid EvaluationIRCCS Azienda Ospedaliero-Universitaria di Bologna
- RECRUITINGNANCT06141369Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001)Shanghai Jiao Tong University School of Medicine
- RECRUITINGNANCT0627718068Ga-TCR-FAPI PET/CT Guided Precision Surgery for MTCCancer Institute and Hospital, Chinese Academy of Medical Sciences
- RECRUITINGPHASE1NCT06520319Head-to-head Study of 68Ga-MGS5 Versus 68Ga-DOTATATE PET/CT in Patients With Medullary Thyroid CarcinomaFirst Affiliated Hospital of Fujian Medical University